MALDI TOF imaging mass spectrometry in clinical pathology: a valuable tool for cancer diagnostics (review).

Matrix-assisted laser desorption/ionization (MALDI) time-of-flight (TOF) imaging mass spectrometry (IMS) is an evolving technique in cancer diagnostics and combines the advantages of mass spectrometry (proteomics), detection of numerous molecules, and spatial resolution in histological tissue sections and cytological preparations. This method allows the detection of proteins, peptides, lipids, carbohydrates or glycoconjugates and small molecules.Formalin-fixed paraffin-embedded tissue can also be investigated by IMS, thus, this method seems to be an ideal tool for cancer diagnostics and biomarker discovery. It may add information to the identification of tumor margins and tumor heterogeneity. The technique allows tumor typing, especially identification of the tumor of origin in metastatic tissue, as well as grading and may provide prognostic information. IMS is a valuable method for the identification of biomarkers and can complement histology, immunohistology and molecular pathology in various fields of histopathological diagnostics, especially with regard to identification and grading of tumors.

[1]  R. Caprioli,et al.  Molecular imaging of biological samples: localization of peptides and proteins using MALDI-TOF MS. , 1997, Analytical chemistry.

[2]  M. Monden,et al.  Extraction and Analysis of Diagnostically Useful Proteins from Formalin-fixed, Paraffin-embedded Tissue Sections , 1998, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[3]  池田 公正.  Extraction and Analysis of Diagnostically Useful Proteins from Formalin-fixed, Paraffin-embedded Tissue Sections , 1999 .

[4]  M. Stoeckli,et al.  Imaging mass spectrometry: A new technology for the analysis of protein expression in mammalian tissues , 2001, Nature Medicine.

[5]  Bill C. White,et al.  Proteomic patterns of tumour subsets in non-small-cell lung cancer , 2003, The Lancet.

[6]  Walter A. Korfmacher,et al.  Direct analysis of drug candidates in tissue by matrix-assisted laser desorption/ionization mass spectrometry. , 2003, Journal of mass spectrometry : JMS.

[7]  Mahlon D. Johnson,et al.  Protein Profiling in Brain Tumors Using Mass Spectrometry , 2004, Clinical Cancer Research.

[8]  Dean Billheimer,et al.  Integrating histology and imaging mass spectrometry. , 2004, Analytical chemistry.

[9]  Roy A Jensen,et al.  Proteomics in diagnostic pathology: profiling and imaging proteins directly in tissue sections. , 2004, The American journal of pathology.

[10]  Richard M Caprioli,et al.  Early Changes in Protein Expression Detected by Mass Spectrometry Predict Tumor Response to Molecular Therapeutics , 2004, Cancer Research.

[11]  D. Larsimont,et al.  Evaluation of HER-2/NEU Protein Expression in Breast Cancer by Immunohistochemistry: An Interlaboratory Study Assessing the Reproducibility of HER-2/NEU Testing , 2002, Breast Cancer Research and Treatment.

[12]  Yu Shyr,et al.  Proteomic-based prognosis of brain tumor patients using direct-tissue matrix-assisted laser desorption ionization mass spectrometry. , 2005, Cancer research.

[13]  Yu Shyr,et al.  Proteomic patterns and prediction of glomerulosclerosis and its mechanisms. , 2005, Journal of the American Society of Nephrology : JASN.

[14]  K. Elenitoba-Johnson,et al.  Identification of proteins from formalin-fixed paraffin-embedded cells by LC-MS/MS , 2005, Laboratory Investigation.

[15]  Benoit M Dawant,et al.  Three-dimensional visualization of protein expression in mouse brain structures using imaging mass spectrometry , 2005, Journal of the American Society for Mass Spectrometry.

[16]  S. Merchant,et al.  Efficient method for the proteomic analysis of fixed and embedded tissues. , 2005, Journal of proteome research.

[17]  Yu Shyr,et al.  Proteomic patterns of preinvasive bronchial lesions. , 2005, American journal of respiratory and critical care medicine.

[18]  R. Caprioli.  Deciphering protein molecular signatures in cancer tissues to aid in diagnosis, prognosis, and therapy. , 2005, Cancer research.

[19]  Brian L Hood,et al.  Proteomic Analysis of Formalin-fixed Prostate Cancer Tissue*S , 2005, Molecular & Cellular Proteomics.

[20]  Richard M Caprioli,et al.  A Novel Histology-directed Strategy for MALDI-MS Tissue Profiling That Improves Throughput and Cellular Specificity in Human Breast Cancer* , 2006, Molecular & Cellular Proteomics.

[21]  B. Balgley,et al.  Protein Extraction from Formalin-fixed, Paraffin-embedded Tissue Sections: Quality Evaluation by Mass Spectrometry , 2006, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[22]  A. Benabid,et al.  Direct-tissue SELDI-TOF mass spectrometry analysis: a new application for clinical proteomics. , 2006, Clinical chemistry.

[23]  Gerhard Jakse,et al.  Identifying prostate carcinoma by MALDI-Imaging. , 2007, International journal of molecular medicine.

[24]  P. Chaurand,et al.  Processing MALDI Mass Spectra to Improve Mass Spectral Direct Tissue Analysis. , 2007, International journal of mass spectrometry.

[25]  J. Nährig,et al.  Quantitative protein analysis from formalin‐fixed tissues: implications for translational clinical research and nanoscale molecular diagnosis , 2007, The Journal of pathology.

[26]  Charles R. Cantor,et al.  Automated comparative sequence analysis by base-specific cleavage and mass spectrometry for nucleic acid-based microbial typing , 2007, Proceedings of the National Academy of Sciences.

[27]  Patrick Ducoroy,et al.  Specific MALDI imaging and profiling for biomarker hunting and validation: fragment of the 11S proteasome activator complex, Reg alpha fragment, is a new potential ovary cancer biomarker. , 2007, Journal of proteome research.

[28]  M. Clench,et al.  Matrix-assisted laser desorption/ionization-ion mobility separation-mass spectrometry imaging of vinblastine in whole body tissue sections. , 2008, Analytical chemistry.

[29]  Pierre P Massion,et al.  High‐throughput proteomic analysis of formalin‐fixed paraffin‐embedded tissue microarrays using MALDI imaging mass spectrometry , 2008, Proteomics.

[30]  Andrea Urbani,et al.  Protein unlocking procedures of formalin‐fixed paraffin‐embedded tissues: Application to MALDI‐TOF Imaging MS investigations , 2008, Proteomics.

[31]  Ariel Y Deutch,et al.  Imaging mass spectrometry of proteins and peptides: 3D volume reconstruction , 2008, Nature Methods.

[32]  R. Caprioli,et al.  Imaging mass spectrometry: Towards clinical diagnostics , 2008, Proteomics. Clinical applications.

[33]  S. Hewitt,et al.  A well‐based reverse‐phase protein array applicable to extracts from formalin‐fixed paraffin‐embedded tissue , 2008, Proteomics. Clinical applications.

[34]  Sandra Rauser,et al.  MALDI imaging mass spectrometry for direct tissue analysis: a new frontier for molecular histology , 2008, Histochemistry and Cell Biology.

[35]  Sören-Oliver Deininger,et al.  MALDI imaging combined with hierarchical clustering as a new tool for the interpretation of complex human cancers. , 2008, Journal of proteome research.

[36]  Richard M Caprioli,et al.  Molecular imaging of proteins in tissues by mass spectrometry , 2008, Proceedings of the National Academy of Sciences.

[37]  Lisa H Cazares,et al.  Imaging Mass Spectrometry of a Specific Fragment of Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Kinase Kinase 2 Discriminates Cancer from Uninvolved Prostate Tissue , 2009, Clinical Cancer Research.

[38]  Royston Goodacre,et al.  Imaging mass spectrometry using chemical inkjet printing reveals differential protein expression in human oral squamous cell carcinoma. , 2009, The Analyst.

[39]  T. Luider,et al.  Sample preparation issues for tissue imaging by imaging MS , 2009, Proteomics.

[40]  P. Selby,et al.  Development and validation of a novel protein extraction methodology for quantitation of protein expression in formalin‐fixed paraffin‐embedded tissues using western blotting , 2009, The Journal of pathology.

[41]  P. Chaurand,et al.  From Whole-body Sections Down to Cellular Level, Multiscale Imaging of Phospholipids by MALDI Mass Spectrometry* , 2010, Molecular & Cellular Proteomics.

[42]  Michelle L. Reyzer,et al.  Gastric cancer-specific protein profile identified using endoscopic biopsy samples via MALDI mass spectrometry. , 2010, Journal of proteome research.

[43]  Richard M Caprioli,et al.  Molecular analysis of tumor margins by MALDI mass spectrometry in renal carcinoma. , 2010, Journal of proteome research.

[44]  Allen Tannenbaum,et al.  Imaging of meningioma progression by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. , 2010, Analytical chemistry.

[45]  H. Shim,et al.  Molecular proteomics imaging of tumor interfaces by mass spectrometry. , 2010, Journal of proteome research.

[46]  Kristina Schwamborn,et al.  Molecular imaging by mass spectrometry — looking beyond classical histology , 2010, Nature Reviews Cancer.

[47]  Michelle L. Reyzer,et al.  Direct molecular analysis of whole-body animal tissue sections by MALDI imaging mass spectrometry. , 2010, Methods in molecular biology.

[48]  M. Clench,et al.  Novel molecular tumour classification using MALDI–mass spectrometry imaging of tissue micro-array , 2010, Analytical and bioanalytical chemistry.

[49]  R. Heeren,et al.  Multimodal mass spectrometric imaging of small molecules reveals distinct spatio-molecular signatures in differentially metastatic breast tumor models. , 2010, Cancer research.

[50]  Ying Liu,et al.  Elevation of sulfatides in ovarian cancer: An integrated transcriptomic and lipidomic analysis including tissue-imaging mass spectrometry , 2010, Molecular Cancer.

[51]  Stefano Ferrero,et al.  Serum biomarkers of renal cell carcinoma assessed using a protein profiling approach based on ClinProt technique. , 2010, Urology.

[52]  [Update on protein analysis of fixed tissues]. , 2010, Der Pathologe.

[53]  M. Setou,et al.  Imaging mass spectrometry of gastric carcinoma in formalin‐fixed paraffin‐embedded tissue microarray , 2010, Cancer science.

[54]  Michael Becker,et al.  Revisiting Rat Spermatogenesis with MALDI Imaging at 20-μm Resolution* , 2010, Molecular & Cellular Proteomics.

[55]  A. Rosenwald,et al.  Application of MALDI imaging for the diagnosis of classical Hodgkin lymphoma , 2010, Journal of Cancer Research and Clinical Oncology.

[56]  Detlev Suckau,et al.  Classification of HER2 receptor status in breast cancer tissues by MALDI imaging mass spectrometry. , 2010, Journal of proteome research.

[57]  André M Deelder,et al.  Imaging mass spectrometry of myxoid sarcomas identifies proteins and lipids specific to tumour type and grade, and reveals biochemical intratumour heterogeneity , 2010, The Journal of pathology.

[58]  H. Höfler,et al.  Neues zur Proteinanalytik archivierter Gewebeproben , 2010, Der Pathologe.

[59]  Richard M Caprioli,et al.  Protein signatures for survival and recurrence in metastatic melanoma. , 2011, Journal of proteomics.

[60]  Richard M Caprioli,et al.  MALDI imaging mass spectrometry of human tissue: method challenges and clinical perspectives. , 2011, Trends in biotechnology.

[61]  R. Caprioli,et al.  Lung cancer diagnosis from proteomic analysis of preinvasive lesions. , 2011, Cancer research.

[62]  Jean-Michel Camadro,et al.  Imaging mass spectrometry provides fingerprints for distinguishing hepatocellular carcinoma from cirrhosis. , 2011, Journal of proteome research.

[63]  M. Spiteller,et al.  Chemical basis of the synergism and antagonism in microbial communities in the nests of leaf-cutting ants , 2011, Proceedings of the National Academy of Sciences.

[64]  W. Schellenberger,et al.  Oral brush biopsy analysis by matrix assisted laser desorption/ionisation-time of flight mass spectrometry profiling--a pilot study. , 2011, Oral oncology.

[65]  S. Nelson,et al.  Recent advances in single-cell MALDI mass spectrometry imaging and potential clinical impact , 2011, Expert review of proteomics.

[66]  Brendan L Wilkinson,et al.  Site‐specific characterisation of densely O‐glycosylated mucin‐type peptides using electron transfer dissociation ESI‐MS/MS , 2011, Electrophoresis.

[67]  N. Voelcker,et al.  MALDI-MS-imaging of whole human lens capsule. , 2011, Journal of proteome research.

[68]  R. Caprioli,et al.  Race disparities in Wilms tumor incidence and biology. , 2011, The Journal of surgical research.

[69]  S. Rauser,et al.  S100-A10, thioredoxin, and S100-A6 as biomarkers of papillary thyroid carcinoma with lymph node metastasis identified by MALDI Imaging , 2011, Journal of Molecular Medicine.

[70]  S. Venz,et al.  Stage-Related Alterations in Renal Cell Carcinoma – Comprehensive Quantitative Analysis by 2D-DIGE and Protein Network Analysis , 2011, PloS one.

[71]  Kristina Schwamborn,et al.  Imaging of Intact Tissue Sections: Moving beyond the Microscope* , 2011, The Journal of Biological Chemistry.

[72]  Zoltan Takats,et al.  Mass spectrometry imaging with high resolution in mass and space (HR2 MSI) for reliable investigation of drug compound distributions on the cellular level , 2011, Analytical and bioanalytical chemistry.

[73]  S. Rauser,et al.  MALDI imaging identifies prognostic seven-protein signature of novel tissue markers in intestinal-type gastric cancer. , 2011, The American journal of pathology.

[74]  K. Schwamborn,et al.  MALDI imaging as a specific diagnostic tool for routine cervical cytology specimens. , 2011, International journal of molecular medicine.

[75]  P. Chaurand,et al.  Mass spectrometry for the evaluation of cardiovascular diseases based on proteomics and lipidomics , 2011, Thrombosis and Haemostasis.

[76]  P. Chaurand,et al.  Advances in proteomic strategies toward the early detection of lung cancer. , 2011, Proceedings of the American Thoracic Society.

[77]  L. Jeng,et al.  Direct tissue analysis by MALDI-TOF mass spectrometry in human hepatocellular carcinoma. , 2011, Clinica chimica acta; international journal of clinical chemistry.

[78]  R. Casadonte,et al.  Proteomic analysis of formalin-fixed paraffin-embedded tissue by MALDI imaging mass spectrometry , 2011, Nature Protocols.

[79]  M. R. Groseclose,et al.  MALDI imaging mass spectrometry: bridging biology and chemistry in drug development. , 2011, Bioanalysis.

[80]  J. Zo,et al.  Lipid MALDI profile classifies non-small cell lung cancers according to the histologic type. , 2012, Lung cancer.

[81]  Horst Zitzelsberger,et al.  Tumor classification of six common cancer types based on proteomic profiling by MALDI imaging. , 2012, Journal of proteome research.

[82]  M. Kriegsmann,et al.  MALDI MS imaging as a powerful tool for investigating synovial tissue , 2012, Scandinavian journal of rheumatology.

[83]  Gwang Ha Kim,et al.  Identification of S100A8 and S100A9 as negative regulators for lymph node metastasis of gastric adenocarcinoma. , 2012, Histology and histopathology.

[84]  K. Schwamborn,et al.  Proteomic tissue profiling for the improvement of grading of noninvasive papillary urothelial neoplasia. , 2012, Clinical biochemistry.

[85]  Richard J A Goodwin,et al.  Sample preparation for mass spectrometry imaging: small mistakes can lead to big consequences. , 2012, Journal of proteomics.

[86]  Pierre Chaurand,et al.  Imaging mass spectrometry of thin tissue sections: a decade of collective efforts. , 2012, Journal of proteomics.

[87]  X. Qin,et al.  Proteomic studies in breast cancer (Review). , 2012, Oncology letters.

[88]  P. Kochanek,et al.  Mapping of phospholipids by MALDI imaging (MALDI-MSI): realities and expectations. , 2012, Chemistry and physics of lipids.

[89]  L. Willmitzer,et al.  High-resolution plant metabolomics: from mass spectral features to metabolites and from whole-cell analysis to subcellular metabolite distributions. , 2012, The Plant journal : for cell and molecular biology.

[90]  Richard M Caprioli,et al.  Imaging Mass Spectrometry—A New and Promising Method to Differentiate Spitz Nevi From Spitzoid Malignant Melanomas , 2012, The American Journal of dermatopathology.

[91]  Stefan K. Maier,et al.  MALDI Imaging Mass Spectrometry for In Situ Proteomic Analysis of Preneoplastic Lesions in Pancreatic Cancer , 2012, PloS one.

[92]  Marius Ueffing,et al.  MALDI imaging mass spectrometry reveals COX7A2, TAGLN2 and S100-A10 as novel prognostic markers in Barrett's adenocarcinoma. , 2012, Journal of proteomics.

[93]  R. Caprioli,et al.  Laser Beam Filtration for High Spatial Resolution MALDI Imaging Mass Spectrometry , 2013, Journal of The American Society for Mass Spectrometry.

[94]  Nathan Heath Patterson,et al.  Histology-driven data mining of lipid signatures from multiple imaging mass spectrometry analyses: application to human colorectal cancer liver metastasis biopsies. , 2013, Analytical chemistry.

[95]  Richard M Caprioli,et al.  Analysis of tissue specimens by matrix-assisted laser desorption/ionization imaging mass spectrometry in biological and clinical research. , 2013, Chemical reviews.

[96]  Bernhard Kuster,et al.  Comprehensive Identification of Proteins from MALDI Imaging* , 2013, Molecular & Cellular Proteomics.

[97]  Masaru Furuta,et al.  The significance of microscopic mass spectrometry with high resolution in the visualisation of drug distribution , 2013, Scientific Reports.

[98]  Heinz Höfler,et al.  MALDI imaging mass spectrometry in cancer research: combining proteomic profiling and histological evaluation. , 2013, Clinical biochemistry.

[99]  B. Döme,et al.  Experimental models to study drug distributions in tissue using MALDI mass spectrometry imaging. , 2013, Journal of proteome research.

[100]  Amit Arora,et al.  Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry: a Fundamental Shift in the Routine Practice of Clinical Microbiology , 2013, Clinical Microbiology Reviews.

[101]  Peter Hoffmann,et al.  Tryptic peptide reference data sets for MALDI imaging mass spectrometry on formalin-fixed ovarian cancer tissues. , 2013, Journal of proteome research.

[102]  Malte Buchholz,et al.  MALDI mass spectrometric imaging based identification of clinically relevant signals in prostate cancer using large‐scale tissue microarrays , 2013, International journal of cancer.

[103]  R. Caprioli,et al.  Imaging the clear cell renal cell carcinoma proteome. , 2013, The Journal of urology.

[104]  Marcello Trevisani,et al.  Impact of Drug Administration Route on Drug Delivery and Distribution into the Lung: An Imaging Mass Spectrometry Approach , 2013, European journal of mass spectrometry.

[105]  Takahiro Hayasaka,et al.  MALDI Imaging Mass Spectrometry-A Mini Review of Methods and Recent Developments. , 2013, Mass spectrometry.

[106]  D. Volmer,et al.  Lipid imaging by mass spectrometry - a review. , 2013, The Analyst.

[107]  Robin Patel.  MALDI-TOF mass spectrometry: transformative proteomics for clinical microbiology. , 2013, Clinical chemistry.

[108]  R. Caprioli,et al.  Proteomic patterns of colonic mucosal tissues delineate Crohn's colitis and ulcerative colitis , 2013, Proteomics. Clinical applications.

[109]  J. Engh,et al.  Ambient mass spectrometry for the intraoperative molecular diagnosis of human brain tumors. , 2013, Neurosurgery.

[110]  Isaiah Norton,et al.  Molecular imaging of drug transit through the blood-brain barrier with MALDI mass spectrometry imaging , 2013, Scientific Reports.

[111]  Fulvio Magni,et al.  Imaging mass spectrometry: a new tool for kidney disease investigations. , 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[112]  Michelle L. Reyzer,et al.  Identification of promethazine as an amyloid-binding molecule using a fluorescence high-throughput assay and MALDI imaging mass spectrometry☆ , 2013, NeuroImage: Clinical.

[113]  M. Reid Groseclose,et al.  A mimetic tissue model for the quantification of drug distributions by MALDI imaging mass spectrometry. , 2013, Analytical chemistry.

[114]  Bernhard Spengler,et al.  Mass spectrometry imaging with high resolution in mass and space , 2013, Histochemistry and Cell Biology.

[115]  R. Heeren,et al.  Mass spectrometry images acylcarnitines, phosphatidylcholines, and sphingomyelin in MDA-MB-231 breast tumor models[S] , 2013, Journal of Lipid Research.

[116]  R. Caprioli,et al.  Matrix-assisted laser desorption ionization imaging mass spectrometry: in situ molecular mapping. , 2013, Biochemistry.

[117]  R. Casadonte,et al.  Imaging mass spectrometry to discriminate breast from pancreatic cancer metastasis in formalin‐fixed paraffin‐embedded tissues , 2014, Proteomics.

[118]  Eric P. Skaar,et al.  Advanced mass spectrometry technologies for the study of microbial pathogenesis. , 2014, Current opinion in microbiology.

[119]  Y. Fujimura,et al.  MALDI Mass Spectrometry Imaging for Visualizing In Situ Metabolism of Endogenous Metabolites and Dietary Phytochemicals , 2014, Metabolites.

[120]  K. Chapman,et al.  Lipidomics in situ: insights into plant lipid metabolism from high resolution spatial maps of metabolites. , 2014, Progress in lipid research.

[121]  H. Olsson,et al.  A new look at drugs targeting malignant melanoma—An application for mass spectrometry imaging , 2014, Proteomics.

[122]  W. Kim,et al.  Imaging Mass Spectrometry in Papillary Thyroid Carcinoma for the Identification and Validation of Biomarker Proteins , 2014, Journal of Korean medical science.

[123]  V. Adam,et al.  MALDI-TOF MS as evolving cancer diagnostic tool: a review. , 2014, Journal of pharmaceutical and biomedical analysis.

[124]  L. Márk,et al.  Mass Spectrometric Identification of Ancient Proteins as Potential Molecular Biomarkers for a 2000-Year-Old Osteogenic Sarcoma , 2014, PloS one.

[125]  F. Pieruzzi,et al.  MALDI imaging mass spectrometry in glomerulonephritis: feasibility study , 2014, Histopathology.

[126]  R. Cramer,et al.  MALDI mass spectrometry in prostate cancer biomarker discovery. , 2014, Biochimica et biophysica acta.

[127]  Benjamin A. Neely,et al.  MALDI imaging mass spectrometry profiling of proteins and lipids in clear cell renal cell carcinoma , 2014, Proteomics.

[128]  R. Linding,et al.  Identification of hypoxia-regulated proteins using MALDI-mass spectrometry imaging combined with quantitative proteomics. , 2014, Journal of proteome research.

[129]  H. Phillips,et al.  Distribution of the Phosphatidylinositol 3-Kinase Inhibitors Pictilisib (GDC-0941) and GNE-317 in U87 and GS2 Intracranial Glioblastoma Models—Assessment by Matrix-Assisted Laser Desorption Ionization Imaging , 2014, Drug Metabolism and Disposition.

[130]  K. Dreisewerd.  Recent methodological advances in MALDI mass spectrometry , 2014, Analytical and Bioanalytical Chemistry.

[131]  N. Bec,et al.  Complementarity of MALDI and LA ICP mass spectrometry for platinum anticancer imaging in human tumor. , 2014, Metallomics : integrated biometal science.

[132]  R. Casadonte,et al.  MALDI Imaging of predictive ferritin, fibrinogen and proteases in haemophilic arthropathy , 2014, Haemophilia : the official journal of the World Federation of Hemophilia.

[133]  Garry L Corthals,et al.  MSiMass list: a public database of identifications for protein MALDI MS imaging. , 2014, Journal of proteome research.

[134]  A rapid ex vivo tissue model for optimising drug detection and ionisation in MALDI imaging studies , 2014, Histochemistry and Cell Biology.

[135]  A. Walch,et al.  In situ drug and metabolite analysis [corrected] in biological and clinical research by MALDI MS imaging. , 2014, Bioanalysis.

[136]  Y. Kogure,et al.  Multiplex genomic profiling of non–small cell lung cancers from the LETS phase III trial of first-line S-1/carboplatin versus paclitaxel/carboplatin: results of a West Japan Oncology Group study , 2014, Oncotarget.

[137]  M. Kwiatkowski,et al.  MALDI imaging-based identification of prognostically relevant signals in bladder cancer using large-scale tissue microarrays. , 2014, Urologic oncology.

[138]  Karin Gorzolka,et al.  MALDI mass spectrometry imaging of formalin-fixed paraffin-embedded tissues in clinical research. , 2014, Histology and histopathology.

[139]  Richard M Caprioli,et al.  MALDI imaging mass spectrometry: spatial molecular analysis to enable a new age of discovery. , 2014, Journal of proteomics.

[140]  Manfred Schmitt,et al.  Multicenter matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI MSI) identifies proteomic differences in breast-cancer-associated stroma. , 2014, Journal of proteome research.

[141]  R. Caprioli.  Imaging mass spectrometry: Molecular microscopy for enabling a new age of discovery , 2014, Proteomics.

[142]  H. Schlüter,et al.  MALDI imaging on tissue microarrays identifies molecular features associated with renal cell cancer phenotype. , 2014, Anticancer research.

[143]  M. Holčapek,et al.  Distribution study of atorvastatin and its metabolites in rat tissues using combined information from UHPLC/MS and MALDI-Orbitrap-MS imaging , 2014, Analytical and Bioanalytical Chemistry.

[144]  F. Pagni,et al.  Proteomics for the diagnosis of thyroid lesions: preliminary report , 2015, Cytopathology : official journal of the British Society for Clinical Cytology.

[145]  D. Harvey.  Analysis of carbohydrates and glycoconjugates by matrix‐assisted laser desorption/ionization mass spectrometry: An update for 2009–2010 , 2014, Mass spectrometry reviews.